iDOCorg's profile picture. The Institute for Diabetes, Obesity, and Cardiovascular Disease provides integrated educational information about the related conditions.

iDOC

@iDOCorg

The Institute for Diabetes, Obesity, and Cardiovascular Disease provides integrated educational information about the related conditions.

Diabetic retinopathy tool utilizing iPhone fb.me/2OId6z2P8


iDOC | The Institute for Diabetes, Obesity, and Cardiovascular Disease fb.me/2qQ6ANmzu


More about the Bionic Pancreas fb.me/3spIaAeW6


DPP-4 helps manage risk of hypoglycemia in elderly. fb.me/2EcTkx3di


Results from new study. fb.me/6txCT6GAR


FDA recommends inhaled insulin for approval fb.me/6UHwXSkho


Struggling with Obesity: A Tale of Victory medscape.com/viewarticle/82… fb.me/1UgsQiC0W


Sanofi cancels diabetes drug pitch--for now--as GLP-1 competition races ahead fb.me/2ZlKFqKYe


Perspective The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience William R.... fb.me/2sbuO3Xb0


Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes — NEJM fb.me/US9SSEP7


Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus — NEJM fb.me/1TTyPZeKQ


In close race with Amgen, Regeneron expands late-stage PCSK9 program fb.me/2vbK9fIpI


GlaxoSmithKline's new diabetes drug faces delay at the FDA fb.me/25u4oX19B


Coaching, counseling help weight-loss success, experts say fb.me/2BoY96Yme


NAFLD resolution lowers diabetes risk in study fb.me/38o5RlGTZ


FDA goes after companies selling illegal diabetes drugs fb.me/WQUi2ys8


Loading...

Something went wrong.


Something went wrong.